
Amicus Therapeutics CEO John Crowley
Goldman Sachs Talks
Enzyme Replacement Therapy
Bill O'Reilly: I was frustrated because of this race against time. Took me about a year or two to really understand the science and the field and the medicine. And i met some great researchers in europe an the netherlands at duke university. There wen't a lot of people working on pompey, but there were a few. You ended going with university oklahoma.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.